Johnson & Johnson

JNJ ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $94.19B $88.82B $85.16B $94.94B $93.78B $82.58B $82.06B $81.58B
Consumer Health $0 $0 $0 $14.95B $14.64B $14.05B $13.90B $13.85B
Pharmaceutical / Innovative Medicine $60.40B $56.96B $54.76B $52.56B $52.08B $45.57B $42.20B $40.73B
Medical Devices / MedTech $33.79B $31.86B $30.40B $27.43B $27.06B $22.96B $25.96B $26.99B
Cost of Revenue $30.26B $27.47B $26.55B $23.40B $28.43B $27.56B $27.09B
Gross Profit $63.94B $61.35B $58.61B $55.34B $54.16B $54.50B $54.49B
Gross Margin 67.9% 69.1% 68.8% 58.3% 57.8% 66.4% 66.8%
Operating Expenses
Research & Development $109.0M $1.84B $483.0M $0
SG&A Expense $23.68B $22.87B $21.51B $20.12B $22.08B $22.18B $22.54B
Operating Income $32.58B $16.69B $15.83B $19.36B $16.70B $17.65B $19.00B
Operating Margin 34.6% 18.8% 18.6% 20.4% 17.8% 21.5% 23.3%
Interest Expense $772.0M $183.0M $201.0M $318.0M $1.01B
Pretax Income $32.58B $16.69B $15.06B $19.18B $16.50B $17.33B $18.00B
Income Tax Expense $5.78B $2.62B $1.74B $1.38B $1.78B $2.21B $2.70B
Net Income $26.80B $14.07B $35.15B $20.88B $14.71B $15.12B $15.30B
Net Margin 28.5% 15.8% 41.3% 22.0% 15.7% 18.4% 18.8%
EPS (Basic) $11.13 $5.84 $13.88 $7.93 $5.59 $5.72 $5.70
EPS (Diluted) $11.03 $5.79 $13.72 $7.81 $5.51 $5.63 $5.61
Shares Outstanding (Basic) 2.41B 2.41B 2.53B 2.63B 2.63B 2.63B 2.65B 2.68B
Shares Outstanding (Diluted) 2.43B 2.43B 2.56B 2.67B 2.67B 2.63B 2.68B 2.73B
Dividends Per Share $5.14 $4.91 $4.70 $4.19 $3.98 $3.75 $3.54
← Newer Page 1 of 3 Older →